Moreover, macroH2A1 KD cells showed typical CSC features: they became resistant to doxorubicin and sorafenib, two of the most used chemotherapeutics against HCC, and to hypoxia through hypoxia inducible factor (HIFα1) up-regulation. The gene discussed is MACROH2A1; the disease is hepatocellular carcinoma.